Advertisement covers CROI 2013

CROI 2013: The Latest on HIV Cure Research (Video)

April 3, 2013

HIV activist and educator Matt Sharp sits down to talk with Steven Deeks, M.D., David Margolis, M.D., and Sharon Lewin, M.D., to discuss the latest developments in HIV cure research coming out of CROI 2013. They talk about research surrounding ways to measure and characterize the latent HIV reservoir, using vorinostat (SAHA) to flush HIV out of the reservoir, the role of inflammation in cure research, and developments in gene therapy.

More on the panelists:

  • Steven Deeks, M.D., is professor of medicine at University of California, San Francisco.
  • David Margolis, M.D., is professor of medicine, microbiology and immunology, and epidemiology, at the School of Medicine, University of North Carolina Chapel Hill.
  • Sharon Lewin, M.D., is infectious diseases physician and head of the Department of Infectious Diseases (DID) in the Central Clinical School, Monash University, as well as Head of the Infectious Diseases Unit at The Alfred Hospital.

The video above has been cross-posted on with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website to watch more video interviews from the conference, as well as earlier meetings.



Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.